These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 33182332)

  • 21. Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease.
    Chen HH; Chang PC; Chen C; Chan MH
    Pharmacol Rep; 2018 Aug; 70(4):668-676. PubMed ID: 29909247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
    Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
    J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins.
    Goes ATR; Jesse CR; Antunes MS; Lobo Ladd FV; Lobo Ladd AAB; Luchese C; Paroul N; Boeira SP
    Chem Biol Interact; 2018 Jan; 279():111-120. PubMed ID: 29054324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease.
    Datla KP; Christidou M; Widmer WW; Rooprai HK; Dexter DT
    Neuroreport; 2001 Dec; 12(17):3871-5. PubMed ID: 11726811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.
    De Araújo FM; Frota AF; de Jesus LB; Macedo TC; Cuenca-Bermejo L; Sanchez-Rodrigo C; Ferreira KMS; de Oliveira JVR; de Fatima Dias Costa M; Segura-Aguilar J; Costa SL; Herrero MT; Silva VDA
    Cell Mol Neurobiol; 2023 Jan; 43(1):265-281. PubMed ID: 34988761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson's Disease in Rats.
    Mao Z; Liu C; Ji S; Yang Q; Ye H; Han H; Xue Z
    Neurochem Res; 2017 Apr; 42(4):1104-1115. PubMed ID: 28247334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.
    Park HJ; Lim S; Joo WS; Yin CS; Lee HS; Lee HJ; Seo JC; Leem K; Son YS; Kim YJ; Kim CJ; Kim YS; Chung JH
    Exp Neurol; 2003 Mar; 180(1):93-8. PubMed ID: 12668152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
    Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
    Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laurus nobilis leaf extract controls inflammation by suppressing NLRP3 inflammasome activation.
    Lee EH; Shin JH; Kim SS; Lee H; Yang SR; Seo SR
    J Cell Physiol; 2019 May; 234(5):6854-6864. PubMed ID: 30387132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
    Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
    J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
    Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N
    Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the Serum Urate Level Can Predict the Development of Parkinsonism in the 6-Hydroxydopamine Animal Model.
    Sarukhani MR; Haghdoost-Yazdi H; Khandan-Chelarci G
    Neurochem Res; 2018 May; 43(5):1086-1095. PubMed ID: 29616443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyphenols from Toona sinensiss Seeds Alleviate Neuroinflammation Induced by 6-Hydroxydopamine Through Suppressing p38 MAPK Signaling Pathway in a Rat Model of Parkinson's Disease.
    Zhuang W; Cai M; Li W; Chen C; Wang Y; Lv E; Fu W
    Neurochem Res; 2020 Sep; 45(9):2052-2064. PubMed ID: 32556929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antrodia camphorata polysaccharide resists 6-OHDA-induced dopaminergic neuronal damage by inhibiting ROS-NLRP3 activation.
    Han C; Shen H; Yang Y; Sheng Y; Wang J; Li W; Zhou X; Guo L; Zhai L; Guan Q
    Brain Behav; 2020 Nov; 10(11):e01824. PubMed ID: 32902155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
    Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.